Wearable and implantable artificial kidney devices for end‐stage kidney disease treatment: Current status and review
Artificial Organs · 2023-04 · 47 (4) · 649-666
DOI: 10.1111/aor.14396 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Artificial Organs, online erschienen am 21.09.2022. Verfasst von Thomas Groth und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department Biomedical Materials, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany. Hauptthemen laut MEDLINE: Kidneys, Artificial, Kidney Failure, Chronic, Renal Insufficiency, Chronic, Wearable Electronic Devices. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Nierstichting, Njurforeningen Vasterbotten, Sweden.
Abstract (Originalsprache)
Background
Chronic kidney disease (CKD) is a major cause of early death worldwide. By 2030, 14.5 million people will have end‐stage kidney disease (ESKD, or CKD stage 5), yet only 5.4 million will receive kidney replacement therapy (KRT) due to economic, social, and political factors. Even for those who are offered KRT by various means of dialysis, the life expectancy remains far too low. Observation Researchers from different fields of artificial organs collaborate to overcome the challenges of creating products such as Wearable and/or Implantable Artificial Kidneys capable of providing long‐term effective physiologic kidney functions such as removal of uremic toxins, electrolyte homeostasis, and fluid regulation. A focus should be to develop easily accessible, safe, and inexpensive KRT options that enable a good quality of life and will also be available for patients in less‐developed regions of the world.
Conclusions
Hence, it is required to discuss some of the limits and burdens of transplantation and different techniques of dialysis, including those performed at home. Furthermore, hurdles must be considered and overcome to develop wearable and implantable artificial kidney devices that can help to improve the quality of life and life expectancy of patients with CKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department Biomedical Materials, Institute of Pharmacy, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
- International Federation for Artificial Organs, Painesville, Ohio, USA.
- Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden.
- HemoCleanse Technologies, Lafayette, Indiana, USA.
- IMEC, Eindhoven, The Netherlands.
- Department of Nephrology, University Medical Centre, Utrecht, The Netherlands.
ORCID-Profile: Thomas Groth, Fokko P Wieringa
Förderung
- Deutsche Forschungsgemeinschaft
- Nierstichting
- Njurforeningen Vasterbotten, Sweden
Zitieren
APA
Groth, T., Stegmayr, B. G., Ash, S. R., Kuchinka, J., Wieringa, F. P., Fissell, W. H., & Roy, S. (2023). Wearable and implantable artificial kidney devices for end‐stage kidney disease treatment: Current status and review. Artificial Organs, 47(4), 649-666. https://doi.org/10.1111/aor.14396
Vancouver
Groth T, Stegmayr BG, Ash SR, Kuchinka J, Wieringa FP, Fissell WH, et al. Wearable and implantable artificial kidney devices for end‐stage kidney disease treatment: Current status and review. Artificial Organs. 2023;47(4):649-666. doi:10.1111/aor.14396
BibTeX
@article{Groth2023,
author = {Groth, Thomas and Stegmayr, Bernd G and Ash, Stephen R and Kuchinka, Janna and Wieringa, Fokko P and Fissell, William H and Roy, Shuvo},
title = {Wearable and implantable artificial kidney devices for end‐stage kidney disease treatment: Current status and review},
journal = {Artificial Organs},
year = {2023},
volume = {47},
number = {4},
pages = {649--666},
doi = {10.1111/aor.14396}
}
EUVIMED